New Recommendations Ai to Ease Patient Access to Lung Cancer Clinical Trials
A new approach to determining admission could boost enrollment numbers and diversity.
Stay updated with breaking news from David Gerber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new approach to determining admission could boost enrollment numbers and diversity.
The FDA plans to push pharmaceutical companies to loosen restrictions so that more people may be eligible for innovative trials for cancer drugs.
A new approach to determining admission could boost enrollment numbers and diversity.
A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill clinical trials and enroll sufficiently diverse groups of patients for results to reflect the broader population, in part because of stringent guidelines on who can participate.
Federal legislation mandates that patients have immediate access to all their medical records. Could that be too much of a good thing?